Daniel Faga - 12 Mar 2026 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Reporting relationship: President, CEO, Director
Issuer ticker: ANAB
Reported as of: 12 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 17:12:19 UTC
Prior SEC filing: 09 Jan 2026
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher Murphy, Attorney-in-Fact

Key filing fact

Daniel Faga filed Form 4 for ANAPTYSBIO, INC (ANAB) on 07 Aug 2026.

Key facts

This page summarizes Daniel Faga's Form 4 filing for ANAPTYSBIO, INC (ANAB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Aug 2026, 17:12.

Change

Previous filing in this sequence was filed on 09 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673528 Primary reporting owner

Faga Daniel

Relationship: President, CEO, Director
Address: C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Christopher Murphy, Attorney-in-Fact
Signature date: 07 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANAB transaction Derivative

Performance Stock Units

Award

Transaction value
Shares: +53,334
Change %
Price: $0.000000^*
Shares after: 53,334
Date: 12 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 53,334
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on March 12, 2026.

Footnote F2

Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

Footnote F3

The PSUs vest and settle over two years; 50% vests on March 12 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.